ArticleGlomerular diseases

Safety and Tolerability of the APOL1 Inhibitor, Inaxaplin, following Single- and Multiple-Ascending Doses in Healthy Adults.

Ogo Egbuna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.